Evaluating the Management of chronic Pelvic girdle Pain following pregnancy (EMaPP): a randomised controlled feasibility trial

Royal Cornwall Hospital Trust0 个研究点目标入组 24 人开始时间: 2021年8月5日最近更新: 2024年5月27日

适应症

试验速览

暂无简介。

•1. Women aged greater than or equal to 18 years
•2. Able and willing to provide informed consent
•3. Self-reported persistent pelvic girdle pain (PGP) (=3 months postpartum)
•4. Self-reported severe PGP (causing walking or stair climbing to be bothersome)
•5. Diagnosed with PGP in line with European guidelines
•6. PGP must have started or been aggravated during pregnancy, as determined by self report

•1. Known allergy to lycra
•2. Age <18 years
•3. Currently pregnant
•4. PGP for >2 years post partum
•5. Self reported history of pathologies causative of lumbopelvic pain (e.g. Infection, trauma, cancer)
•6. Participating in concurrent interventional research which may over-burden the patient or confound data collection
•7. There are no special arrangements made for participants who are unable to adequately understand verbal and/or written English. There is no intention to exclude patients, therefore, if they have regular access to a friend or family member who is able to translate for them they would be able to participate
•8. Participants who lack capacity to provide informed consent

发起方

Royal Cornwall Hospital Trust